Skip to content

Preliminary Evaluation of CASTLE Barrier North American Prototype

Peristomal Skin Irritation: A Preliminary Evaluation of CASTLE Barrier North American Prototype

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01413672
Enrollment
30
Registered
2011-08-10
Start date
2011-08-31
Completion date
2011-12-31
Last updated
2011-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peristomal Skin Complication

Keywords

ostomy, colostomy, ileostomy, barrier, irritation

Brief summary

The purpose of this study is to determine if an ostomy barrier that promotes a healthy skin environment will result in reduced peristomal skin irritation.

Interventions

DEVICEUse of CASTLE barrier

Test barrier to be used in place of normal barrier. Otherwise normal routine is followed

Sponsors

Hollister Incorporated
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

at least 18 years of age has colostomy or ileostomy current user of two-piece, flat, tape bordered barrier mild to moderate skin peristomal skin irritation community dwelling and cares for stoma independently at least 3 months post-operative provides informed consent

Exclusion criteria

presence of fistula on or near stoma prior participation in stoma care study within past 30 days pregnant or lactating (interview only) uses convex product, paste and/or rings known allergy to test barrier composition existing medical condition or therapy that might affect ability to participate or interpretation of study results

Design outcomes

Primary

MeasureTime frame
Peristomal skin irritation30 days

Secondary

MeasureTime frameDescription
Security30 dayswear time, lifting of barrier from skin, leakage

Countries

Canada, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026